EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Xlife Sciences AG's enterprise value is CHF257.63 Mil.
Xlife Sciences AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.99 Mil. Therefore, Xlife Sciences AG's EV-to-Revenue for today is 260.76.
The historical rank and industry rank for Xlife Sciences AG's EV-to-Revenue or its related term are showing as below:
XSWX:XLS'
s EV-to-Revenue Range Over the Past 10 Years
Min: 374.86 Med: 440.5 Max: 608.9
Current: 260.76
During the past 6 years, the highest EV-to-Revenue of Xlife Sciences AG was 608.90. The lowest was 374.86. And the median was 440.50.
XSWX:XLS's EV-to-Revenue is ranked worse than 89.51% of 1039
companies
in the Biotechnology industry
Industry Median: 8.37
vs XSWX:XLS: 260.76
As of today (2024-05-12), Xlife Sciences AG's stock price is CHF35.30.
Xlife Sciences AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.14. Therefore, Xlife Sciences AG's PS Ratio for today is 259.56.
Xlife Sciences AG EV-to-Revenue Historical Data
The historical data trend for Xlife Sciences AG's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xlife Sciences AG's EV-to-Revenue
For the Biotechnology subindustry, Xlife Sciences AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xlife Sciences AG's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Xlife Sciences AG's EV-to-Revenue falls into.
Xlife Sciences AG's current Enterprise Value is CHF257.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xlife Sciences AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xlife Sciences AG (XSWX:XLS) EV-to-Revenue Explanation
Xlife Sciences AG's share price for today is CHF35.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xlife Sciences AG EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Xlife Sciences AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:XLS has been successfully added to your 